BACKGROUND: Whole blood platelet aggregometry (impedance) is an important method to investigate platelet function disorders. Examination of hemostatic function in sheep is important with respect to their role as an animal model of human disease. OBJECTIVE: The aim of this study was to evaluate and optimize selected methodological aspects (anticoagulant, agonist concentration) of impedance aggregometry in ovine blood using the new Multiplate 5.0 analyzer. METHODS: Blood samples were collected in hirudin anticoagulant from 40 clinically healthy sheep. Samples from selected sheep were collected in citrate, with or without the addition of calcium chloride. The agonists adenosine diphosphate (ADP), collagen, ristocetin, arachidonic acid, and thrombin receptor-activating peptide (TRAP) were added in several concentrations to induce aggregation. RESULTS: Based on maximum aggregation values and internal precision, no significant difference was found between ADP concentrations of 3-10 micromol/L and collagen concentrations of 3-5 microg/mL (P>.05). The lowest interindividual variation of approximately 3-4-fold was seen with 4 and 5 micromol/L ADP and 4 and 5 microg/mL collagen. Ristocetin, arachidonic acid, and TRAP did not induce significant aggregation at any concentration. Aggregation results were significantly lower when measured in citrate- vs hirudin-anticoagulated blood, regardless of the presence of calcium chloride. CONCLUSIONS: Our results indicate that the multiplate impedance aggregometer is suitable for the measurement of platelet aggregation in sheep using optimal agonist concentrations of 4-5 micromol/L ADP and 4-5 microg/mL collagen. Hirudin-anticoagulated blood is the preferred sample material.
BACKGROUND: Whole blood platelet aggregometry (impedance) is an important method to investigate platelet function disorders. Examination of hemostatic function in sheep is important with respect to their role as an animal model of human disease. OBJECTIVE: The aim of this study was to evaluate and optimize selected methodological aspects (anticoagulant, agonist concentration) of impedance aggregometry in ovine blood using the new Multiplate 5.0 analyzer. METHODS: Blood samples were collected in hirudin anticoagulant from 40 clinically healthy sheep. Samples from selected sheep were collected in citrate, with or without the addition of calcium chloride. The agonists adenosine diphosphate (ADP), collagen, ristocetin, arachidonic acid, and thrombin receptor-activating peptide (TRAP) were added in several concentrations to induce aggregation. RESULTS: Based on maximum aggregation values and internal precision, no significant difference was found between ADP concentrations of 3-10 micromol/L and collagen concentrations of 3-5 microg/mL (P>.05). The lowest interindividual variation of approximately 3-4-fold was seen with 4 and 5 micromol/L ADP and 4 and 5 microg/mL collagen. Ristocetin, arachidonic acid, and TRAP did not induce significant aggregation at any concentration. Aggregation results were significantly lower when measured in citrate- vs hirudin-anticoagulated blood, regardless of the presence of calcium chloride. CONCLUSIONS: Our results indicate that the multiplate impedance aggregometer is suitable for the measurement of platelet aggregation in sheep using optimal agonist concentrations of 4-5 micromol/L ADP and 4-5 microg/mL collagen. Hirudin-anticoagulated blood is the preferred sample material.
Authors: William J Weiss; Elizabeth L Carney; J Brian Clark; Rebecca Peterson; Timothy K Cooper; Thomas P Nifong; Christopher A Siedlecki; Dennis Hicks; Bradley Doxtater; Branka Lukic; Eric Yeager; John Reibson; Joshua Cysyk; Gerson Rosenberg; William S Pierce Journal: ASAIO J Date: 2012 Jan-Feb Impact factor: 2.872
Authors: Lara M Heimgartner; Martina Stirn; Annette P N Kutter; Nadja E Sigrist; Rahel Jud Schefer Journal: J Vet Diagn Invest Date: 2021-10-15 Impact factor: 1.569
Authors: Margaret R Passmore; Yoke L Fung; Gabriela Simonova; Samuel R Foley; Sara D Diab; Kimble R Dunster; Michelle M Spanevello; Charles I McDonald; John-Paul Tung; Natalie M Pecheniuk; Karen Hay; Kiran Shekar; John F Fraser Journal: Crit Care Date: 2017-07-29 Impact factor: 9.097
Authors: Sarah Heringer; Lisa Kabelitz; Martin Kramer; Omid Nikoubashman; Marc A Brockmann; Stefanie Kirschner; Martin Wiesmann Journal: PLoS One Date: 2019-08-29 Impact factor: 3.240
Authors: Annika Weigand; Anja M Boos; Jürgen Ringwald; Maren Mieth; Ulrich Kneser; Andreas Arkudas; Oliver Bleiziffer; Dorothee Klumpp; Raymund E Horch; Justus P Beier Journal: BMC Vet Res Date: 2013-10-03 Impact factor: 2.741
Authors: Nicolas J Prat; Andrew D Meyer; Thomas Langer; Robbie K Montgomery; Bijaya K Parida; Andriy I Batchinsky; Andrew P Cap Journal: Shock Date: 2015-12 Impact factor: 3.454